��������

Klaus Shao's most recent work experience was as a Senior Biological Researcher at METiS Therapeutics starting in May 2022. Prior to that, they worked as a Scientists at Q² Solutions from June 2021 to May 2022. Their previous role was as a Detection Researcher at Biocytogen from July 2020 to June 2021.

Klaus Shao's education history begins in 2013 when they attended Hebei Agricultural University for four years. During this time, they pursued a degree in Pharmaceutical Engineering. After completing their undergraduate studies in 2017, they joined Nankai University and focused on Medicinal Chemistry. Klaus spent the next three years at Nankai University, obtaining a Master's degree in Medicinal Chemistry, which they completed in 2020.